What is the recommended treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cellulitis

For typical cases of cellulitis without systemic signs of infection, an antimicrobial agent active against streptococci is recommended for 5 days, with treatment extension if the infection has not improved within this time period. 1, 2

Classification and Initial Assessment

  • Severity classification:

    • Mild: No systemic signs of infection
    • Moderate: Systemic signs of infection present
    • Severe: SIRS, altered mental status, or hemodynamic instability
  • Risk factors for MRSA to assess:

    • Penetrating trauma
    • Evidence of MRSA infection elsewhere
    • Nasal colonization with MRSA
    • Injection drug use
    • Systemic inflammatory response syndrome (SIRS)
    • Recent antibiotic use in previous 4-6 weeks 2

Antibiotic Treatment Recommendations

Mild Cellulitis (Outpatient)

  • First-line: Antimicrobial agent active against streptococci 1
    • Penicillin VK 250-500 mg orally every 6 hours (for facial cellulitis) 2
    • Cephalexin 500 mg 3-4 times daily 2

Moderate Cellulitis

  • First-line: Consider coverage for both streptococci and MSSA 1
    • Amoxicillin-clavulanate 875/125 mg twice daily orally 2
    • Clindamycin 300-450 mg orally three times daily 2

Severe Cellulitis (Inpatient)

  • First-line: Vancomycin 15-20 mg/kg IV every 8-12 hours (covers both MRSA and streptococci) 2
  • Alternative options:
    • Cefazolin 1-2 g IV every 8 hours
    • Nafcillin/oxacillin 1-2 g IV every 4-6 hours 2

For Severely Compromised Patients

  • Combination therapy: Vancomycin plus piperacillin-tazobactam or imipenem/meropenem 1, 2

Treatment Duration

  • Standard duration: 5 days 1, 2
  • Extend treatment if infection has not improved within 5 days 1, 2

Adjunctive Measures

  1. Elevation of the affected area to reduce swelling 1, 2
  2. Treatment of predisposing factors such as edema or underlying cutaneous disorders 1, 2
  3. Examination of interdigital toe spaces in lower-extremity cellulitis to treat fissuring, scaling, or maceration 1, 2
  4. Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adult patients 1, 2

Hospitalization Criteria

Hospitalization is recommended if:

  • Concern for deeper or necrotizing infection
  • Poor adherence to therapy
  • Infection in severely immunocompromised patient
  • Outpatient treatment is failing
  • SIRS, altered mental status, or hemodynamic instability present 1, 2

Transition from IV to Oral Therapy

  • Switch to oral therapy after clinical improvement with IV antibiotics
  • Maintain the same antimicrobial spectrum when transitioning 2

Prevention of Recurrent Cellulitis

  • Identify and treat predisposing conditions:

    • Edema
    • Obesity
    • Eczema
    • Venous insufficiency
    • Toe web abnormalities 1, 2
  • For patients with 3-4 episodes per year: Consider prophylactic antibiotics

    • Oral penicillin or erythromycin twice daily for 4-52 weeks
    • Intramuscular benzathine penicillin every 2-4 weeks 1

Special Considerations

  • Blood cultures are not routinely recommended but should be obtained in patients with malignancy on chemotherapy, neutropenia, severe cell-mediated immunodeficiency, immersion injuries, and animal bites 1
  • Patients who have received antibiotics in the previous 4-6 weeks should be given an alternative class or higher-dose regimen 2
  • Immunocompromised patients may require broader coverage and longer duration of therapy 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cellulitis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.